Informed consent for research

Informed consent for research

Informed consent for research

On this page

Fundamental Ethical Principles in Research

  • Primary Distinction: Research's main goal is generating generalizable knowledge, not direct patient benefit. This must be explicitly clear to the participant.
  • Governing Bodies: All research is overseen by an Institutional Review Board (IRB) under federal regulations (the "Common Rule").
  • Essential Elements:
    • Clear statement of research purpose, procedures, and duration.
    • Description of foreseeable risks, discomforts, and potential benefits.
    • Disclosure of appropriate alternative procedures.
    • Assurance of confidentiality.
    • Confirmation that participation is voluntary with the right to withdraw at any time without penalty.

⭐ The IRB's foremost responsibility is to protect the rights and welfare of human research subjects, acting as an independent ethics committee.

Full disclosure is a prerequisite for valid informed consent in research. It ensures the participant is fully aware of what their participation entails. Key components can be recalled with the mnemonic below.

  • 📌 Mnemonic: "BRAIN-CV"
    • Benefits: A description of any potential benefits to the subject or to others.
    • Risks: A description of any reasonably foreseeable risks or discomforts.
    • Alternatives: Disclosure of appropriate alternative procedures or courses of treatment.
    • Information & Confidentiality: A statement on how confidentiality of records will be maintained.
    • Nature & Purpose: An explanation of the research's purpose and the expected duration of participation.
    • Contact Information: Who to contact for answers about the research, subject's rights, and in case of injury.
    • Voluntary Participation: A statement that participation is voluntary and refusal or discontinuation will involve no penalty or loss of benefits.

⭐ For research involving more than minimal risk, an explanation as to whether any compensation and/or medical treatments are available if injury occurs must be provided.

Vulnerable Subjects - Handle with Care

Certain populations require extra protection during research due to potential coercion or undue influence. The Institutional Review Board (IRB) must ensure safeguards are in place.

  • Key Vulnerable Groups:

    • Children & Minors
    • Pregnant Women, Fetuses, Neonates
    • Prisoners
    • Cognitively Impaired Individuals
    • Economically or Educationally Disadvantaged
  • Requirements:

    • Research must be vital and not possible with non-vulnerable subjects.
    • Consent procedures are more stringent.

⭐ For minors, assent (agreement from the child) must be obtained if they are capable, in addition to consent from parents/legal guardians.

Institutional Review Board - Research Referee

  • Primary Mandate: Protect the rights & welfare of human research subjects before and during their participation in research.
  • Composition: Requires at least 5 members with diverse backgrounds to ensure a comprehensive review.
    • Must include scientists and non-scientists.
    • At least one member with a non-scientific focus (e.g., lawyer, ethicist, clergy).
    • At least one member unaffiliated with the institution.
  • Key Functions: Risk-benefit analysis, protocol review, and ensuring proper informed consent.

⭐ The IRB has the authority to approve, require modifications to, or disapprove all research activities involving human subjects.

  • Informed consent for research is distinct from clinical consent and requires Institutional Review Board (IRB) approval.
  • Must clearly state the study's purpose, risks, benefits, and alternatives.
  • Participation is strictly voluntary; subjects can withdraw at any time without penalty.
  • Requires special safeguards for vulnerable populations like children or prisoners.
  • Investigators must avoid all forms of coercion or undue influence.
  • Assurances of confidentiality are a mandatory component.

Practice Questions: Informed consent for research

Test your understanding with these related questions

A research team develops a new monoclonal antibody checkpoint inhibitor for advanced melanoma that has shown promise in animal studies as well as high efficacy and low toxicity in early phase human clinical trials. The research team would now like to compare this drug to existing standard of care immunotherapy for advanced melanoma. The research team decides to conduct a non-randomized study where the novel drug will be offered to patients who are deemed to be at risk for toxicity with the current standard of care immunotherapy, while patients without such risk factors will receive the standard treatment. Which of the following best describes the level of evidence that this study can offer?

1 of 5

Flashcards: Informed consent for research

1/6

SVC syndrome can be caused by _____ from indwelling central venous catheters

TAP TO REVEAL ANSWER

SVC syndrome can be caused by _____ from indwelling central venous catheters

thromboemboli

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial